2014
DOI: 10.1080/00914037.2014.886238
|View full text |Cite
|
Sign up to set email alerts
|

Preparation and Drug Release of Aspirin-Loaded PLGA-PEG-PLGA/Montmorillonite Microparticles

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(3 citation statements)
references
References 28 publications
0
3
0
Order By: Relevance
“…The incorporation of PLGA with MMT has been investigated by several groups for oral delivery of therapeutic agents using the mucoadhesive capability of MMT in crossing nanoparticles through GI barrier. The ratio of MMT to PLGA in these studies is 10–40% (w/w). There is only one study reporting the use of PLGA-MMT as an iv drug delivery system in which the MMT/PLGA ratio is 0.042% .…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The incorporation of PLGA with MMT has been investigated by several groups for oral delivery of therapeutic agents using the mucoadhesive capability of MMT in crossing nanoparticles through GI barrier. The ratio of MMT to PLGA in these studies is 10–40% (w/w). There is only one study reporting the use of PLGA-MMT as an iv drug delivery system in which the MMT/PLGA ratio is 0.042% .…”
Section: Resultsmentioning
confidence: 99%
“…The successful incorporation of MMT with polymeric materials via the intercalation process has led to the use of clay–polymer nanocomposites in many fields of applications including drug delivery to a special target. , Poly­( d , l -lactide- co -glycolide) (PLGA) is one of the most known biodegradable and biocompatible polymers used in drug targeting studies. Incorporation of PLGA with MMT for preparation of controlled release oral nanodrug delivery systems (NDDS) has been the subject in many studies. The ratio of MMT to PLGA in these studies is 10–40% (w/w). According to the best of our knowledge, there is only one report on the preparation and characterization of PLGA-MMT NDDS for intravenous (iv) application by Sun et al in which the ratio of MMT to PLGA is designed as 0.042%.…”
Section: Introductionmentioning
confidence: 99%
“…Aspirin from primary times of marketing approval became a drug effective for common inflammations, fever, and pain reduction. Liu et al [96] loaded aspirin in PLGA-PEG-PLGA copolymers while additionally checking the impact of including organic montmorillonite (o-MMT) in microspheres. MPs containing higher concentrations of montmorillonite show a faster rate of drug release despite the irregular effects of the first few hours.…”
Section: Microparticles Based On Amphiphilic Pla/peg and Plga/peg Cop...mentioning
confidence: 99%